Toronto Dominion Bank’s COSCIENS Biopharma Inc. Common Stock CSCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-199
Closed -$1K 1471
2024
Q2
$1K Buy
+199
New +$1.52K ﹤0.01% 1237
2023
Q4
Sell
-593
Closed -$5.92K 1848
2023
Q3
$5.92K Buy
+593
New +$6.58K ﹤0.01% 1322
2022
Q3
Sell
-408
Closed -$8K 1743
2022
Q2
$8K Buy
408
+112
+38% +$2.8K ﹤0.01% 1204
2022
Q1
$11K Sell
296
-15
-5% -$539 ﹤0.01% 1272
2021
Q4
$11K Buy
311
+175
+129% +$9.22K ﹤0.01% 1398
2021
Q3
$10K Buy
136
+27
+25% +$1.92K ﹤0.01% 1281
2021
Q2
$9K Sell
109
-19
-15% -$1.81K ﹤0.01% 1261
2021
Q1
$15K Sell
128
-157
-55% -$17.4K ﹤0.01% 1286
2020
Q4
$12K Buy
+285
New +$10.5K ﹤0.01% 1229
2020
Q3
Sell
-1
Closed 1363
2020
Q2
$0 Buy
+1
New +$92 ﹤0.01% 1394
2020
Q1
Sell
-29
Closed -$3K 1490
2019
Q4
$3K Hold
29
﹤0.01% 1265
2019
Q3
$3K Buy
29
+28
+2,800% +$6.06K ﹤0.01% 1366
2019
Q2
$0 Hold
1
﹤0.01% 1792
2019
Q1
$0 Buy
+1
New +$388 ﹤0.01% 1770
2018
Q4
Sell
-4
Closed -$1K 1689
2018
Q3
$1K Buy
4
+3
+300% +$550 ﹤0.01% 1350
2018
Q2
$0 Hold
1
﹤0.01% 1583
2018
Q1
$0 Hold
1
﹤0.01% 1434
2017
Q4
$0 Buy
+1
New +$208 ﹤0.01% 1313
2017
Q3
Hold
0
1253
2017
Q2
Hold
0
1292
2017
Q1
Hold
0
1292
2016
Q3
Hold
0
1267
2016
Q2
Hold
0
1317
2016
Q1
Sell
-1
Closed 1299
2015
Q4
$0 Buy
+1
New +$628 ﹤0.01% 1109
2015
Q3
Hold
0
1118
2015
Q2
Hold
0
1152

Other funds holding CSCI

Toronto Dominion Bank's CSCI Position: Q3 2024 in Review

Toronto Dominion Bank sold out of COSCIENS Biopharma Inc. Common Stock (CSCI) in Q3 2024, closing a stake of 199 shares — an estimated $1K sold.

Toronto Dominion Bank first reported a position in CSCI in Q4 2015 and held it in 19 quarters. The position peaked at $15K in Q1 2021. 9 funds tracked by Wall St. Rank hold CSCI as of Q3 2024.

  • Toronto Dominion Bank reported no remaining COSCIENS Biopharma Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Toronto Dominion Bank sold 199 COSCIENS Biopharma Inc. Common Stock shares in Q3 2024, an estimated $1K.
  • Toronto Dominion Bank first reported a position in COSCIENS Biopharma Inc. Common Stock in Q4 2015 and held it in 19 quarters.
  • Toronto Dominion Bank's COSCIENS Biopharma Inc. Common Stock position peaked at $15K in Q1 2021.
  • 9 funds tracked by Wall St. Rank held COSCIENS Biopharma Inc. Common Stock as of Q3 2024.

Based on Toronto Dominion Bank's 13F filing for Q3 2024, filed 14 Nov 2024.